These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25311071)

  • 21. Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach.
    Verdecchia P; Angeli F; Bartolini C; De Filippo V; Aita A; Di Giacomo L; Poltronieri C; Lip GY; Reboldi G
    Expert Opin Drug Saf; 2015 Jan; 14(1):7-20. PubMed ID: 25311731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban.
    Frost C; Song Y; Barrett YC; Wang J; Pursley J; Boyd RA; LaCreta F
    Clin Pharmacol; 2014; 6():179-87. PubMed ID: 25419161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACP Journal Club: in nonvalvular atrial fibrillation, effects of rivaroxaban compared with warfarin did not differ by patient age.
    Rondina M
    Ann Intern Med; 2014 Nov; 161(10):JC5. PubMed ID: 25402538
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversal agents in development for the new oral anticoagulants.
    Costin J; Ansell J; Laulicht B; Bakhru S; Steiner S
    Postgrad Med; 2014 Nov; 126(7):19-24. PubMed ID: 25387210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran.
    Getta B; Muller N; Motum P; Hsu D; Zebeljan D; Rosenfeld D
    Br J Haematol; 2015 May; 169(4):603-4. PubMed ID: 25425051
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban.
    Gosselin RC; Adcock D; Hawes EM; Francart SJ; Grant RP; Moll S
    Thromb Haemost; 2015 Jan; 113(1):77-84. PubMed ID: 25413383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
    Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.
    Zahir H; Brown KS; Vandell AG; Desai M; Maa JF; Dishy V; Lomeli B; Feussner A; Feng W; He L; Grosso MA; Lanz HJ; Antman EM
    Circulation; 2015 Jan; 131(1):82-90. PubMed ID: 25403645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When the rubber meets the road: adherence and persistence with non-vitamin K antagonist oral anticoagulants and old oral anticoagulants in the real world-a problem or a myth ?
    Suryanarayan D; Schulman S
    Semin Thromb Hemost; 2014 Nov; 40(8):852-9. PubMed ID: 25384183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on ''gastrointestinal bleeding under dabigatran''.
    Gélisse P; Crespel A
    J Postgrad Med; 2014; 60(4):413-4. PubMed ID: 25370556
    [No Abstract]   [Full Text] [Related]  

  • 31. The importance of postapproval data for dabigatran.
    Redberg RF
    JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
    [No Abstract]   [Full Text] [Related]  

  • 32. Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.
    Dzeshka MS; Lip GY
    Expert Opin Drug Saf; 2015 Jan; 14(1):45-62. PubMed ID: 25341529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings.
    Verhoef TI; Redekop WK; Hasrat F; de Boer A; Maitland-van der Zee AH
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):451-62. PubMed ID: 25326294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation.
    Wang Y; Xie F; Kong MC; Lee LH; Ng HJ; Ko Y
    Cardiovasc Drugs Ther; 2014 Dec; 28(6):575-85. PubMed ID: 25319314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of partial portal vein thrombosis (PVT) with low dose rivaroxaban.
    Lenz K; Dieplinger B; Buder R; Piringer P; Rauch M; Voglmayr M
    Z Gastroenterol; 2014 Oct; 52(10):1175-7. PubMed ID: 25313630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis".
    Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2014 Nov; 130(22):e195. PubMed ID: 25421051
    [No Abstract]   [Full Text] [Related]  

  • 37. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal.
    Chan NC; Siegal D; Lauw MN; Ginsberg JS; Eikelboom JW; Guyatt GH; Hirsh J
    J Thromb Thrombolysis; 2015 Aug; 40(2):231-9. PubMed ID: 25403952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
    Caprio FZ; Bernstein RA; Alberts MJ; Curran Y; Bergman D; Korutz AW; Syed F; Ansari SA; Prabhakaran S
    Cerebrovasc Dis; 2014; 38(4):247-53. PubMed ID: 25401389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of dabigatran in an elderly population: single center experience in Italy.
    Verdecchia P; Molini G; Bartolini C; De Filippo V; Valecchi F; Martone S; Aita A; di Giacomo L; Angeli F; Reboldi G
    Curr Drug Saf; 2015; 10(2):165-9. PubMed ID: 25387822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.